The San Diego-based company said it had a loss of 23 cents per share. The biotechnology company posted revenue of $90,000 in the period. In the ...
News
- Otonomy: Q1 Earnings Snapshot
- Kindred Bio: Q1 Earnings Snapshot
(AP) _ Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $9.7 million in its first quarter. The Burlingame, California-based company said it ...
- Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics
... at The University of Texas Health Science Center at San Antonio. ... INDUSTRY KEYWORD: CARDIOLOGY BIOTECHNOLOGY TECHNOLOGY ...
- Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125
BUSINESS WIRE)-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and ...
- Xenon Pharmaceuticals: Q1 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share. The gene therapy biotech company ...